X0202 SCHEDULE 13G/A 0000929638-24-003915 0001871665 XXXXXXXX LIVE 4 Common Stock, par value $0.0001 per share 03/31/2026 0000034956 TENAX THERAPEUTICS, INC. 88032L605 101 Glen Lennox Drive Suite 300 Chapel Hill NC 27517 Rule 13d-1(c) Lind Global Fund II LP b DE 202480 0 202480 0 202480 N 0.78 PN The reporting person's ownership consists of 202,480 warrants to purchase shares of common stock (the "Warrants"). Such Warrants may not be exercised if, following such exercise, the reporting person's beneficial ownership would exceed 9.9%. Lind Global Partners II LLC b DE 202480 0 202480 0 202480 N 0.78 OO The reporting person's ownership consists of 202,480 Warrants. Such Warrants may not be exercised if, following such exercise, the reporting person's beneficial ownership would exceed 9.9% EASTON JEFF b X1 202480 0 202480 0 202480 N 0.78 IN The reporting person's ownership consists of 202,480 Warrants. Such Warrants may not be exercised if, following such exercise, the reporting person's beneficial ownership would exceed 9.9%. TENAX THERAPEUTICS, INC. 101 Glen Lennox Drive, Suite 300, Chapel Hill, North Carolina, 27517 This statement is filed by the following entities and individuals (collectively, referred to as the "Reporting Persons"): o Lind Global Fund II LP, a Delaware limited partnership; o Lind Global Partners II LLC, a Delaware limited liability company; and o Jeff Easton, an individual and a citizen of the United States of America. Lind Global Partners II LLC, the general partner of Lind Global Fund II LP, may be deemed to have sole voting and dispositive power with respect to the shares held by Lind Global Fund II LP. Jeff Easton, the managing member of Lind Global Partners II LLC, may be deemed to have sole voting and dispositive power with respect to the shares held by Lind Global Fund II LP. The address of the principal business office for each of the Reporting Persons is: 444 Madison Ave, Floor 41 New York, NY 10022 See Row 4 of cover page for each Reporting Person. Y See Row 9 of cover page for each Reporting Person. See Row 11 of cover page for each Reporting Person. See Row 5 of cover page for each Reporting Person. See Row 6 of cover page for each Reporting Person. See Row 7 of cover page for each Reporting Person. See Row 8 of cover page for each Reporting Person. N Y Y Y Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. Lind Global Fund II LP By: Lind Global Partners II LLC, its General Partner, By: /s/ Jeff Easton 05/15/2026 Lind Global Partners II LLC /s/ Jeff Easton 05/15/2026 EASTON JEFF /s/ Jeff Easton 05/15/2026